KALA Projected Dividend Yield
KALA BIO Inc ( NASDAQ : KALA )KALA BIO, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. Co.'s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. Co.'s product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived bio factors, such as growth factors, protease inhibitors, matrix proteins and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. 21 YEAR PERFORMANCE RESULTS |
KALA Dividend History Detail KALA Dividend News KALA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |